Bristol Myers Squibb (NYSE: BMY) closed the latest trading day at $40.75, indicating a -0.9% change from the previous session's end. The stock trailed the S&P 500, which registered a daily loss of 0.88%. Meanwhile, the Dow experienced a rise of 0.08%, and the technology-dominated Nasdaq saw a decrease of 1.95%. Shares of the biopharmaceutical company witnessed a loss of 3.04% over the previous month, trailing the performance of the Medical sector with its loss of 1.09% and the S&P 500's gain of 5.11%. The upcoming earnings release of Bristol Myers Squibb will be of great interest to investors. The company's earnings report is expected on July 26, 2024. On that day, Bristol Myers Squibb is projected to report earnings of $1.66 per share, which would represent a year-over-year decline of 5.14%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $11.45 billion, up 1.96% from ...